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CABG redo increasingly become more and more important both
clinically and economically. METHODS: A retrospective study
was conducted among a population of 256,806 patients with
initial CABG performed during the time period of January 2001
to February 2005. Data were collected from 332 hospitals out
of the Solucient® ACTrackerTM inpatient database. Multivariate
logistic regression was used to identify factors contributed to
CABG performance and propensity score adjustment was
applied. Patient demographic, hospital characteristics (hospital
bed size, region, teaching and PCI annual volume), disease con-
dition (Chronic Obstructive Pulmonary Disease, COPD; Periph-
eral Vascular disease, PVD; Diabetes Mellitus, DM and
Malignancy, MA), related therapeutic drugs class (Anticoagu-
lant, Antiplatelet, GP2b3a, Asprin and Statins) usages during
hospital stay, patient severity and risk adjust mortality index and
on and off pump were introduced to logistic regression analysis.
RESULTS: The patient demographics, hospital characteristics
and disease conditions were controlled for comparison between
CABG and CABG redo population (P > 0.05) except that male
tended to have more CABG redo (OR: 1.2977, CI:
1.0956–1.5371). A total of 581 (0.22%) patients were found to
have undergone CABG redo in an average of 350 days. Con-
comitant drug uses were studied. Anitcoagulant (OR: 3.649, CI:
3.353–3.971) and GP2b3a (OR: 1.480, CI: 1.331–1.647) have
been found to not help with outcomes of the CABG patient while
Asprin (OR: 0.308, CI: 0.28–0.335) and Statin (OR: 0.544, CI:
0.506–0.585) were found to signiﬁcantly impact the outcomes
of CABG performance. CONCLUSIONS: The study conﬁrmed
that patients with CABG redo had worse outcomes than those
with one CABG (5.34% vs. 3.03%, p < 0.01). Detail drug usage
studies are recommended to ﬁnd out how to prevent patients
from CABG redo in the initial treatment.
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OBJECTIVE: The objective of this investigation is to determine
whether the results of myocardial perfusion imaging (MPI) for
detection of coronary artery disease (CAD) results in improved
new health outcomes in asymptomatic patients with Type-2 dia-
betes. The potential value of MPI is highlighted by the demon-
strated association between patients with diabetes mellitus and
the accelerated development of CAD, the fact that myocardial
ischemia due to coronary atherosclerosis is commonly asympto-
matic and the proven improvement in health outcomes in
patients treated with coronary artery bypass grafting (CABG).
METHODS: A retrospective observational study was conducted
using data from a Veterans’ Health System database, which
included detailed diagnosis codes and three-year clinical follow-
up of out-patient and in-patient encounters. We examined
whether the presence of coded diagnoses for angina in patients
also diagnosed with diabetes was associated with increased coro-
nary artery abnormalities detected by MPI; we also examined the
rates of cardiac intervention and subsequent cardiac events. A
total of 517 patients who underwent MPI during the observa-
tion interval were included in the analysis; 520 matched patients
who did not undergo MPI were used for comparison. RESULTS:
Over 31.9% of MPI studies were abnormal and indicated
ischemic or ﬁxed perfusion defects, or both. Forty-one patients
in the MPI cohort experienced cardiac death and 66 suffered MI,
whereas in the comparator cohort 68 (OR 2.4 [95% CI
1.4–6.2]); p < 0.01) suffered cardiac death and 97 suffered MI
(OR 4.4 [95% CI 2.6–9.6]; p < 0.01). The rate of CABG was
approximately four-fold greater in the MPI cohort and the rate
of both PTCA and CABG was three-fold greater in the MPI
cohort. CONCLUSION: Findings from this retrospective analy-
sis of MPI in asymptomatic patients with CAD and Type-2 dia-
betes has demonstrated that MPI resulted in interventions that
reduced hard and soft cardiac events.
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OBJECTIVES: It costs $12 billion annually for the management
of hypertension in U.S. Drug therapy is a major cost associated
with the management of hypertension. The Seventh Report of
the Joint National Committee on Prevention, Detection, Evalu-
ation, and Treatment of High Blood Pressure (JNC-7) issued new
guidelines for hypertension management. One of their guidelines
is that thiazide-type diuretics should be used in the therapy of
most patients with hypertension either alone in combination
with other drugs. Diuretics enhance the efﬁcacy of the multidrug
regimens and are more affordable than other antihypertensive
agents. Despite these recommendations, thiazide diuretics remain
underused. Literature review indicates that patient’ payment
sources might inﬂuence the drug utilization for hypertension.
This study examines the inﬂuence of various patients payment
source on the thiazide diuretics utilization for hypertension in
hospital ambulatory setting. METHODS: Patient payment
sources such as Self Pay, Medicare, Medicaid, HMO’s, and PPO’s
were used as independent variables to determine their inﬂuence
on the thiazide diuretics utilization for hypertensive patients.
Data from the National Hospital Ambulatory Medical Care
Survey (NHAMCS) 2003 were utilized. Patients with principal
diagnosis of Hypertension (ICD-9 code 401–404) were analyzed
using ANOVA, multiple linear and binomial logit regression
models. RESULTS: Hypertensive Patients with Federal source of
payments (Medicaid and Medicare) were prescribed signiﬁcantly
lower number of thiazide diuretics compared to patients with
other sources of payments (R2 = 0.116). Patients with (HMO’s
+ PPO’s) and self-pay as their primary source of payments 
were prescribed signiﬁcantly higher number of thiazide diuretics
compared to patients with other source of payments (R2 = 0.364)
and (R2 = 0.287) respectively. CONCLUSIONS: Thiazide diuret-
ics utilization for hypertensive patients are signiﬁcantly 
inﬂuenced by patients’ source of payments. Patients with
HMO’s, PPO’s and self-pay as their source of payment 
appears to appropriately adhere to the (JNC-7) guidelines for
hypertension.
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OBJECTIVES: Underused and inadequate care can adversely
affect patient health. Missed opportunities often occur in
primary care because process ﬂow models are not optimized to
make effective use of established clinical knowledge. To bridge
the gap between knowledge and practice we tested an electronic
